Sai Parenterals peers

Companies like Sai Parenteralslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAIPARENT₹484.05

Sai Parenterals Limited

· Pharma & Health
₹ CrorePeersINDOCOPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,139 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SAIPARENT
FY26
INDOCO
FY26
PANACEABIO
FY26
HIKAL
FY26
Peer
Average
Valuation — at last close
P/E111.02×————
P/B4.36×2.10×2.42×◆ 2.08×2.20× +98%
EV/EBITDA52.86×20.94×◆ -420.68×14.35×-128.46× +141%
Market Cap₹2,139 Cr₹1,973 Cr₹2,017 Cr₹2,496 Cr₹2,162 Cr -1%
Growth
Revenue CAGR 3Y—3.41%◆ 11.63%-5.40%3.21%
Revenue CAGR 5Y—◆ 8.25%0.47%-0.09%2.88%
Revenue YoY (latest Q)—7.32%◆ 19.72%5.89%10.98%
Net Income YoY (latest Q)—◆ 311.40%-44.44%66.96%111.31%
Profitability
EBITDA Margin10.16%7.68%-0.73%◆ 12.87%6.61% +54%
Net Income Margin◆ 3.74%-5.35%-1.12%-2.85%-3.11% +220%
Return on Common Equity◆ 2.91%-9.70%-0.64%-3.97%-4.77% +161%
Return on Capital Employed2.57%0.97%-4.11%◆ 3.30%0.05% +4719%
Return on Assets◆ 1.00%-3.93%-0.56%-1.99%-2.16% +146%
Credit & Quality
Total Debt/Equity0.65×1.11×◆ 0.03×0.57×0.57× +14%
Interest Coverage◆ 1.18×0.13×-6.23×0.91×-1.73× +168%
Scale — latest FY
Revenue / Total Income₹381 Cr₹1,845 Cr₹640 Cr₹1,713 Cr₹1,399 Cr -73%
Net Income₹14.3 Cr−₹98.7 Cr−₹7.2 Cr−₹48.8 Cr−₹51.6 Cr +128%
Total Assets₹1,424 Cr₹2,593 Cr₹1,262 Cr₹2,365 Cr₹2,074 Cr -31%
EPS₹4.36₹-10.7₹-0.88₹-3.96₹-5.18 +184%
Book Value per Share₹111.08₹101.76₹136.19₹97.07₹111.67 -1%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.